Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Pharmacokinetic studies support chronic dosing of FK-143

Dec. 3, 1998

Health Canada approves first new incontinence medication in over a decade

Dec. 3, 1998

Tamsulosin improves signs and symptoms of BPH in phase III study

Dec. 1, 1998

Pfizer claims new series for BPH with selective prostatic alpha1-adrenoceptor-antagonist effects

Dec. 1, 1998

Japanese researchers present positive findings in Synsorb Pk trial

Nov. 27, 1998

New treatment for aldosterone-related disorders discovered by French research team

Nov. 24, 1998

Dual 5alpha-reductase inhibitors and alpha1-blocking agents prepared at Zeria

Nov. 23, 1998

Agents for nephritis in the Tsumura pipeline

Nov. 19, 1998

Dutasteride outshines finasteride in BPH Rx

Nov. 18, 1998

OPC-21268 improves glomerulonephritis in hypercholesterolemic rats, nephropathy in diabetic rats

Nov. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....